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This Month in the Journal
We focus this month on statistical issues in human ge-
netics, with four articles on a variety of mathematical
tools for the identification and mapping of genetic loci.
Elston (p. 931) reviews the relative merits of various
model-free and model-based linkage methods, and he
ends with a discussion of the significance levels in whole-
genome screens. Schaid (p. 935) discusses the develop-
ment of the haplotype relative risk and the transmission-
disequilibrium tests. He points out various pitfalls in the
application of these and related model-free methods.
Jarvik (p. 942) discusses complex segregation studies,
which, she argues, serve as a valuable first step that
should be taken before one embarks on linkage analysis
of complex genetic traits; she considers the potential
power of this approach, as assessed in simulation studies,
and she also examines its record in real applications to
human disease, such as in the identification of the mode
of transmission of genes that underlie prostate cancer or
breast cancer. Finally, Vieland (p. 947) argues that a
Bayesian approach to linkage analysis is superior, both
practically and in terms of logical consistency, to con-
ventional analyses, which focus on type I error rates. She
finds that metanalysis among independent linkage stud-
ies could be simplified by use of the posterior probability
of linkage (as calculated from Bayes theorem), rather
than the P value of a finding.
Also in this issue, Walhout et al. (p. 955) discuss the
growing importance of the nematode Caenorhabditis
elegans as a model for the study of the development and
physiology of larger animals such as ourselves. With this
worm’s compact genome now almost fully sequenced,
it has become practical to examine, in a comprehensive
and systematic fashion, all the possible interactions
among the proteins that it encodes and to provide this
information freely to the community of researchers.
Congenital Myasthenic Syndrome, by Donger et al.
(p. 967)
Congenital myasthenia syndromes (CMS) may arise
from the loss of acetylcholine receptor function at the
neuromuscular junction (NMJ), because of defects in the
genes for either acetylcholinesterase (AchE) or subunits
of the acetylcholine receptor. In the type Ic form of CMS,
NMJs are abnormal, with small muscle end plates that
contain little or no AChE. Expression of AChE on this
structure of the muscle cell is sensitive to collagenase,
and a unique collagen species, collagen Q, is known to
associate with AChE; this interaction may be lost in
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some families with CMS-Ic. Donger et al. have now
cloned the human collagen Q cDNA, and they have
found a missense mutation in COLQ, which segregates
with a mild form of CMS-Ic in one family. Curiously,
this mutation does not interfere with interactions be-
tween AChE and collagen Q, but it seems to prevent the
localization of the complex to the muscle end plate.
Hairless Gene Mutation in Congenital Atrichia, by
Ahmad et al. (p. 984)
Hair growth in normal mammals is limited by the du-
ration of anagen, the active phase of the hair cycle, dur-
ing which time hair-follicle matrix cells proliferate and
differentiate into the hair root and shaft cells. In people
with congenital atrichia, a single hair cycle proceeds nor-
mally, with the expected shedding of the natal hair, but
the growth fails to resume during the first adult hair
cycle. A similar pattern is seen in mice with homozygous
loss-of-function alleles in the Hairless gene, which en-
codes a zinc-finger–family transcription factor. One mu-
tation in the human homologue, HAIRLESS, has been
identified in a family with autosomal recessive loss of
hair. In that family and in a second family that Ahmad
and colleagues now report, the complete loss of head
and body hair is accompanied by the degeneration of
hair follicles and the growth of cysts in their place. These
findings and a similar phenotype in the mouse mutant
implicate the Hairless protein in transcriptional regu-
lation of follicle and epidermal cell growth and
differentiation.
CpG-Methylation Levels in Human Germ Cells, by El-
Maari et al. (p. 1001)
Methylated cytosines, which occur preferentially in
CpG-rich sequences, are prone to mutations, but it has
not been clear whether this methylation represents a
rate-limiting event in the appearance of mutations in
human genes. Here, El-Maari and co-workers show that
levels of methylation at specific CpG dinucleotides are
poor predictors of mutation rates in oocytes and sper-
matocytes. The authors have examined the methylation
pattern in two genes that are subject to frequent mu-
tation, in DNA from isolated germ cells. They find no
differences that could account for the strong bias for
paternal, rather than maternal, de novo mutations. In
fact, most sites were heavily methylated in both cell
types, and even relatively infrequently methylated sites
can appear as hot spots for mutation. Differences in the
rate of mutation may be found, as the authors suggest,
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in the large number of cell divisions that occur in sper-
matogenesis during a man’s lifetime, relative to the
fixed—and smaller—number of divisions in oogenesis;
different rates of mismatch repair might provide an al-
ternative explanation.
SNRPN in Human Preimplantation Embryos, by
Huntriss et al. (p. 1009)
Huntriss et al. have taken advantage of a common poly-
morphism in the SNRPN gene to follow the temporal
pattern of expression of this maternally imprinted gene
before and shortly after conception. Eggs donated by
women who are heterozygous for this polymorphism
carry SNRPN mRNA derived from both alleles, con-
firming that the imprint has been erased during oogen-
esis. These mRNA species are unstable after fertilization,
however, and by the 4-cell zygote stage, material derived
from the oocyte is undetectable by reverse transcrip-
tion–PCR. When such early preimplantation embryos
are generated in vitro from the gametes of “informative”
couples (in which parents are both homozygous, each
for a different allele), only the paternally derived allele
is expressed. This early developmental imprinting has
also been observed in mice, a species that seems to be
a reliable model of human imprinting.
Phenotypic Variation in VHL Disease, by Webster et
al. (p. 1025)
von Hippel–Lindau (VHL) disease presents with a va-
riety of tumor types, in the nervous system and the kid-
ney and elsewhere. TheVHL defect, which underlies this
familial cancer syndrome, is inherited as a dominant
loss-of-function allele; tumor growth requires a second,
somatic event, which may be epigenetic, rather than ge-
netic. The course of the disease is highly variable among
people hemizygous for a functional VHL allele, but phe-
notypic similarities within families raise the question of
whether modifier genes affect VHL’s presentation or
progression. Webster et al. now address this possibility
by comparing the occurrence of ocular angiomas—a be-
nign tumor type that is easily studied by gonioscopy,
without the need for invasive procedures—in VHL kin-
dreds. All affected members in a single family are ex-
pected to carry an identical mutant allele, and Webster
et al. find significant correlation in the number of an-
giomas within either parent-child pairs or pairs of sib-
lings. However, these correlations are not significant
among more distant relatives, suggesting that some phe-
notypic modifiers are shared only among close relatives.
Whether this effect reflects a shared genetic background,
a common environment, or both remains unknown.
XPD Defects and Clinical Severity in TTD, by Botta et
al. (p. 1036)
The XPB and XPD genes each encode subunits of the
basal transcription-factor–complex TFIIH, and muta-
tions in both of these genes can lead either to xeroderma
pigmentosum (XP) or to the trichothiodystrophy (TTD).
XP causes greatly increased rates of sunlight-induced
skin cancer, whereas TTD is a developmental disorder
that presents with brittle hair. TTD individuals are usu-
ally free from obvious skin symptoms, although some
are extremely prone to sunburn. The absence of skin
tumors in TTD is all the more surprising because TTD
cells exhibit the same nucleotide-excision–repair defect
that is observed in XP. Here, Botta et al. report clinical
heterogeneity even among TTD individuals with lesions
in XPD. The authors have ascertained and studied 11
Italian TTD individuals, and they find that the sensitivity
of their cells to killing by UV is, in all cases, similar to
that observed in XP cells, with no evident correlation
between the XPD genotype and this cell-culture phe-
notype. They note, however, that the clinical features of
TTD, including growth retardation and mental retar-
dation, are most severe in individuals who carry one
presumed null allele (“functional hemizygotes”) as well
as a weak allele.
Attitudes of Deaf Adults toward Genetics, by
Middleton, et al. (p. 1175)
Deafness is traditionally viewed as a disability, but deaf
people often regard their condition more positively, as
an aspect of their identity that gives them access to a
unique linguistic subculture, the Deaf community. Be-
cause of this difference in perception, deaf people may
regard the motivations of genetic researchers and coun-
selors with suspicion, and they may consider the birth
of congenitally deaf children as desirable or even pref-
erable. Middleton and colleagues have tried to measure
the extent and nature of such attitudes in deaf individ-
uals. Here, they show that respondents at an interna-
tional conference on the deaf (all of whom were hearing
impaired, whether or not they were deaf at birth) gen-
erally applied negative descriptors to genetic testing and
to discoveries in human genetics. This hostility was still
more pronounced among those who describe themselves
as belonging to the Deaf culture. Nonetheless, some re-
spondents indicated that they would be interested in pre-
natal testing for deafness, and, of these, a few expressed
a preference for having deaf children.
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